European & Developing Countries Clinical Trials Partnership

EDCTP是欧洲、撒哈拉以南非洲和欧盟国家之间的公共伙伴关系。目前作为EDCTP协会成员参与EDCTP的国家有：14个欧洲国家-奥地利、丹麦、芬兰、法国、德国、爱尔兰、意大利、卢森堡、荷兰、挪威、葡萄牙、西班牙、瑞典、英国;和14个非洲国家-布基纳法索、喀麦隆、刚果、加蓬、冈比亚、加纳、马里、莫桑比克、尼日尔、塞内加尔、南非、坦桑尼亚、乌干达和赞比亚：摩洛哥红十字会每年向这一供资伙伴关系提供捐款，以支持非洲经发现金信托方案的研究和能力建设活动。所有EDCTP资助的项目都是与撒哈拉以南国家合作开展的。EDCTP旨在支持合作研究，加速新的或改进的医疗干预措施的临床开发，以预防或治疗撒哈拉以南非洲的艾滋病毒/艾滋病、结核病、疟疾和被忽视的传染病。（昏睡病）;利什曼病;囊虫病/绦虫病;麦地那龙线虫病（麦地那龙线虫病）;棘球蚴病;食源性吸虫病;淋巴丝虫病;盘尾丝虫病（河盲症）;血吸虫病;土传蠕虫病;布鲁里溃疡;麻风（汉森病）;沙眼;雅司病;尿道感染;下呼吸道感染;以及埃博拉等与非洲特别相关的新出现的传染病。该方案支持在撒哈拉以南非洲进行临床试验和相关研究活动，以及临床试验和相关研究的能力发展。EDCTP 2支持新的或改进的医疗干预措施的所有临床试验阶段（I至IV期），以及新诊断工具的高级测试和现场验证。更多信息可在EDCTP网站上找到：http://www.edctp.org/

EDCTP is a public-public partnership between countries in Europe, sub-Saharan Africa and the European Union. The countries currently participating in EDCTP as members of the EDCTP Association are:14 European countries – Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, UK; and14 African countries – Burkina Faso, Cameroon, Congo, Gabon, The Gambia, Ghana, Mali, Mozambique, Niger, Senegal, South Africa, Tanzania, Uganda and Zambia.MRC contributes annually to this funding partnership to support EDCTP research and capacity building activities. All EDCTP-funded projects are undertaken in partnership with sub-Saharan countries. EDCTP aims to support collaborative research that accelerates the clinical development of new or improved medical interventions to prevent or treat HIV/AIDS, tuberculosis, malaria and neglected infectious diseases in sub-Saharan Africa.EDCTP includes the following neglected infectious diseases: dengue; rabies; human African trypanosomiasis (sleeping sickness); Leishmaniases; cysticercosis/ taeniasis; dracunculiasis (guinea-worm disease); echinococcosis; foodborne trematodiases; lymphatic filariasis; onchocerciasis (river blindness); schistosomiasis; soil-transmitted helminthiases; Buruli ulcer; leprosy (Hansen disease); trachoma; yaws; diarrhoeal infections; lower respiratory infections; as well as emerging infectious diseases of particular relevance for Africa, such as Ebola. The programme supports clinical trials and related research activities on PRDs, as well as capacity development for clinical trials and related research in sub-Saharan Africa. EDCTP2 supports all phases of clinical trials (phases I to IV) for new or improved medical interventions, as well as advanced testing and field validation of new diagnostic tools.Further information can be found on the EDCTP website: http://www.edctp.org/